Lattice Semiconductor Corporation Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? Lattice Semiconductor Corporation Common Stock trades at $126.05 (market cap $17.76B), while Revolution Medicines Inc. Common Stock trades at $189.76 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 2.3× Lattice Semiconductor Corporation Common Stock's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Lattice Semiconductor Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Lattice Semiconductor Corporation Common Stock for 1 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| LSCC | RVMD | |
|---|---|---|
Market Cap | $17.76B | $40.32B |
Volume | 1,802,283 | 4,855,734 |
Sector | Technology | Health |
52-Week High | $155.27 | $221.15 |
52-Week Low | $61.73 | $47.50 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $17.62B | $37.02B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Lattice Semiconductor develops low-power programmable chips, known as FPGAs. Its products are used in communications, computing, industrial, and automotive applications.
Read more on LSCC →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →